Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double Blind, Randomized, Sham-Controlled, Clinical Trial to Evaluate The Safety And Efficacy Of Biometrics-Guided Magnetic EEG Resonance Therapy (MeRT) Treatment Of Post-Traumatic Stress Disorder

NCT02990793 is registered in ClinicalTrials.gov with Wave Neuroscience as lead sponsor.

NCT NCT02990793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02990793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double Blind, Randomized, Sham-Controlled, Clinical Trial to Evaluate The Safety And Efficacy Of Biometrics-Guided Magnetic EEG Resonance Therapy (MeRT) Treatment Of Post-Traumatic Stress Disorder
Lead sponsor
Wave Neuroscience
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2022
Completion date
November 4, 2025
Enrollment
158 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

postconcussive symptoms, posttraumatic stress disorder, traumatic brain injury